世界の樹状細胞がんワクチン市場：市場規模・現状・予測

• 英文タイトル：Global Dendritic Cell Cancer Vaccines Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9N7076
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、108ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当資料は、樹状細胞がんワクチンのグローバル市場について調査・分析したレポートで、種類別（CreaVax、Sipuleucel-T（プロバンジ）、その他）、用途別（小児、大人）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・樹状細胞がんワクチンの世界市場規模
・主要企業別市場シェア
・樹状細胞がんワクチンの世界市場規模：種類別（CreaVax、Sipuleucel-T（プロバンジ）、その他）
・樹状細胞がんワクチンの世界市場規模：用途別（小児、大人）
・樹状細胞がんワクチンのアメリカ市場規模（種類別、用途別）
・樹状細胞がんワクチンのヨーロッパ市場規模（種類別、用途別）
・樹状細胞がんワクチンの中国市場規模（種類別、用途別）
・樹状細胞がんワクチンの日本市場規模（種類別、用途別）
・樹状細胞がんワクチンの東南アジア市場規模（種類別、用途別）
・樹状細胞がんワクチンのインド市場規模（種類別、用途別）
・樹状細胞がんワクチンの中南米市場規模（種類別、用途別）
・主要企業別分析（企業概要、製品動向、販売量など）
・樹状細胞がんワクチンの世界市場予測（2019年-2025年）
・樹状細胞がんワクチンの地域別市場予測（2019年-2025年）
...

Dendritic cells (DCs) refer to rare kind of leukocytes. They have prompted their recent application to therapeutic cancer vaccinations as they are uniquely effective in their ability to present antigens to T cells. Isolated DCs loaded with tumor antigen ex vivo and administered as a cellular vaccine are found to induce protective and therapeutic anti-tumor immunity in experimental animals.Increase in prevalence of cancer, improvement of technology such as drug innovations regarding cancer, upsurge in awareness about cancer and their available therapies in the market, and increase in health care expenditure drive the market.
In 2018, the global Dendritic Cell Cancer Vaccines market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Dendritic Cell Cancer Vaccines status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Dendritic Cell Cancer Vaccines development in United States, Europe and China.

The key players covered in this study
3M Company
Activarti
Argos Therapeutics
Batavia Bioservices
Bellicum Pharmaceuticals
Creagene
DanDrit Biotech
DCPrime
Sanpower Corporation
Elios Therapeutics
ImmunoCellular Therapeutics
Immunicum
Kiromic
Medigene
Merck
Northwest Biotherapeutics
Glaxo Smith Kline
Tellaorporation
Vaxil BioTherapeutics

Market segment by Type, the product can be split into
CreaVax
Sipuleucel-T (Provenge)
Others

Market segment by Application, split into
Pediatrics
Adults

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Dendritic Cell Cancer Vaccines status, future forecast, growth opportunity, key market and key players.
To present the Dendritic Cell Cancer Vaccines development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Dendritic Cell Cancer Vaccines are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Dendritic Cell Cancer Vaccines Market Size Growth Rate by Type (2014-2025)
1.4.2 CreaVax
1.4.3 Sipuleucel-T (Provenge)
1.4.4 Others
1.5 Market by Application
1.5.1 Global Dendritic Cell Cancer Vaccines Market Share by Application (2014-2025)
1.5.2 Pediatrics
1.5.3 Adults
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Dendritic Cell Cancer Vaccines Market Size
2.2 Dendritic Cell Cancer Vaccines Growth Trends by Regions
2.2.1 Dendritic Cell Cancer Vaccines Market Size by Regions (2014-2025)
2.2.2 Dendritic Cell Cancer Vaccines Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Dendritic Cell Cancer Vaccines Market Size by Manufacturers
3.1.1 Global Dendritic Cell Cancer Vaccines Revenue by Manufacturers (2014-2019)
3.1.2 Global Dendritic Cell Cancer Vaccines Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Dendritic Cell Cancer Vaccines Market Concentration Ratio (CR5 and HHI)
3.2 Dendritic Cell Cancer Vaccines Key Players Head office and Area Served
3.3 Key Players Dendritic Cell Cancer Vaccines Product/Solution/Service
3.4 Date of Enter into Dendritic Cell Cancer Vaccines Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Dendritic Cell Cancer Vaccines Market Size by Type (2014-2019)
4.2 Global Dendritic Cell Cancer Vaccines Market Size by Application (2014-2019)

5 United States
5.1 United States Dendritic Cell Cancer Vaccines Market Size (2014-2019)
5.2 Dendritic Cell Cancer Vaccines Key Players in United States
5.3 United States Dendritic Cell Cancer Vaccines Market Size by Type
5.4 United States Dendritic Cell Cancer Vaccines Market Size by Application

6 Europe
6.1 Europe Dendritic Cell Cancer Vaccines Market Size (2014-2019)
6.2 Dendritic Cell Cancer Vaccines Key Players in Europe
6.3 Europe Dendritic Cell Cancer Vaccines Market Size by Type
6.4 Europe Dendritic Cell Cancer Vaccines Market Size by Application

7 China
7.1 China Dendritic Cell Cancer Vaccines Market Size (2014-2019)
7.2 Dendritic Cell Cancer Vaccines Key Players in China
7.3 China Dendritic Cell Cancer Vaccines Market Size by Type
7.4 China Dendritic Cell Cancer Vaccines Market Size by Application

8 Japan
8.1 Japan Dendritic Cell Cancer Vaccines Market Size (2014-2019)
8.2 Dendritic Cell Cancer Vaccines Key Players in Japan
8.3 Japan Dendritic Cell Cancer Vaccines Market Size by Type
8.4 Japan Dendritic Cell Cancer Vaccines Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Dendritic Cell Cancer Vaccines Market Size (2014-2019)
9.2 Dendritic Cell Cancer Vaccines Key Players in Southeast Asia
9.3 Southeast Asia Dendritic Cell Cancer Vaccines Market Size by Type
9.4 Southeast Asia Dendritic Cell Cancer Vaccines Market Size by Application

10 India
10.1 India Dendritic Cell Cancer Vaccines Market Size (2014-2019)
10.2 Dendritic Cell Cancer Vaccines Key Players in India
10.3 India Dendritic Cell Cancer Vaccines Market Size by Type
10.4 India Dendritic Cell Cancer Vaccines Market Size by Application

11 Central & South America
11.1 Central & South America Dendritic Cell Cancer Vaccines Market Size (2014-2019)
11.2 Dendritic Cell Cancer Vaccines Key Players in Central & South America
11.3 Central & South America Dendritic Cell Cancer Vaccines Market Size by Type
11.4 Central & South America Dendritic Cell Cancer Vaccines Market Size by Application

12 International Players Profiles
12.1 3M Company
12.1.1 3M Company Company Details
12.1.2 Company Description and Business Overview
12.1.3 Dendritic Cell Cancer Vaccines Introduction
12.1.4 3M Company Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)
12.1.5 3M Company Recent Development
12.2 Activarti
12.2.1 Activarti Company Details
12.2.2 Company Description and Business Overview
12.2.3 Dendritic Cell Cancer Vaccines Introduction
12.2.4 Activarti Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)
12.2.5 Activarti Recent Development
12.3 Argos Therapeutics
12.3.1 Argos Therapeutics Company Details
12.3.2 Company Description and Business Overview
12.3.3 Dendritic Cell Cancer Vaccines Introduction
12.3.4 Argos Therapeutics Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)
12.3.5 Argos Therapeutics Recent Development
12.4 Batavia Bioservices
12.4.1 Batavia Bioservices Company Details
12.4.2 Company Description and Business Overview
12.4.3 Dendritic Cell Cancer Vaccines Introduction
12.4.4 Batavia Bioservices Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)
12.4.5 Batavia Bioservices Recent Development
12.5 Bellicum Pharmaceuticals
12.5.1 Bellicum Pharmaceuticals Company Details
12.5.2 Company Description and Business Overview
12.5.3 Dendritic Cell Cancer Vaccines Introduction
12.5.4 Bellicum Pharmaceuticals Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)
12.5.5 Bellicum Pharmaceuticals Recent Development
12.6 Creagene
12.6.1 Creagene Company Details
12.6.2 Company Description and Business Overview
12.6.3 Dendritic Cell Cancer Vaccines Introduction
12.6.4 Creagene Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)
12.6.5 Creagene Recent Development
12.7 DanDrit Biotech
12.7.1 DanDrit Biotech Company Details
12.7.2 Company Description and Business Overview
12.7.3 Dendritic Cell Cancer Vaccines Introduction
12.7.4 DanDrit Biotech Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)
12.7.5 DanDrit Biotech Recent Development
12.8 DCPrime
12.8.1 DCPrime Company Details
12.8.2 Company Description and Business Overview
12.8.3 Dendritic Cell Cancer Vaccines Introduction
12.8.4 DCPrime Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)
12.8.5 DCPrime Recent Development
12.9 Sanpower Corporation
12.9.1 Sanpower Corporation Company Details
12.9.2 Company Description and Business Overview
12.9.3 Dendritic Cell Cancer Vaccines Introduction
12.9.4 Sanpower Corporation Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)
12.9.5 Sanpower Corporation Recent Development
12.10 Elios Therapeutics
12.10.1 Elios Therapeutics Company Details
12.10.2 Company Description and Business Overview
12.10.3 Dendritic Cell Cancer Vaccines Introduction
12.10.4 Elios Therapeutics Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)
12.10.5 Elios Therapeutics Recent Development
12.11 ImmunoCellular Therapeutics
12.12 Immunicum
12.13 Kiromic
12.14 Medigene
12.15 Merck
12.16 Northwest Biotherapeutics
12.17 Glaxo Smith Kline
12.18 Tellaorporation
12.19 Vaxil BioTherapeutics

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Dendritic Cell Cancer Vaccines Key Market Segments
Table Key Players Dendritic Cell Cancer Vaccines Covered
Table Global Dendritic Cell Cancer Vaccines Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Dendritic Cell Cancer Vaccines Market Size Market Share by Type 2014-2025
Figure CreaVax Figures
Table Key Players of CreaVax
Figure Sipuleucel-T (Provenge) Figures
Table Key Players of Sipuleucel-T (Provenge)
Figure Others Figures
Table Key Players of Others
Table Global Dendritic Cell Cancer Vaccines Market Size Growth by Application 2014-2025 (Million US$)
Figure Pediatrics Case Studies
Figure Adults Case Studies
Figure Dendritic Cell Cancer Vaccines Report Years Considered
Table Global Dendritic Cell Cancer Vaccines Market Size 2014-2025 (Million US$)
Figure Global Dendritic Cell Cancer Vaccines Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Dendritic Cell Cancer Vaccines Market Size by Regions 2014-2025 (Million US$)
Table Global Dendritic Cell Cancer Vaccines Market Size by Regions 2014-2019 (Million US$)
Table Global Dendritic Cell Cancer Vaccines Market Share by Regions 2014-2019
Figure Global Dendritic Cell Cancer Vaccines Market Share by Regions 2014-2019
Figure Global Dendritic Cell Cancer Vaccines Market Share by Regions 2019
Table Market Top Trends
Table Global Dendritic Cell Cancer Vaccines Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Dendritic Cell Cancer Vaccines Market Share by Manufacturers (2014-2019)
Figure Global Dendritic Cell Cancer Vaccines Market Share by Manufacturers in 2018
Table Global Dendritic Cell Cancer Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Dendritic Cell Cancer Vaccines Product/Solution/Service
Table Date of Enter into Dendritic Cell Cancer Vaccines Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Dendritic Cell Cancer Vaccines Market Size by Type (2014-2019) (Million US$)
Table Global Dendritic Cell Cancer Vaccines Market Size Share by Type (2014-2019)
Figure Global Dendritic Cell Cancer Vaccines Market Size Market Share by Type (2014-2019)
Table Global Dendritic Cell Cancer Vaccines Market Size by Application (2014-2019) (Million US$)
Table Global Dendritic Cell Cancer Vaccines Market Size Share by Application (2014-2019)
Figure Global Dendritic Cell Cancer Vaccines Market Size Market Share by Application (2014-2019)
Figure Global Dendritic Cell Cancer Vaccines Revenue Market Share by Application in 2018
Figure United States Dendritic Cell Cancer Vaccines Market Size 2014-2019 (Million US$)
Table United States Key Players Dendritic Cell Cancer Vaccines Revenue (2018-2019) (Million US$)
Table United States Key Players Dendritic Cell Cancer Vaccines Market Share (2018-2019)
Table United States Dendritic Cell Cancer Vaccines Market Size by Type (2014-2019) (Million US$)
Table United States Dendritic Cell Cancer Vaccines Market Share by Type (2014-2019)
Table United States Dendritic Cell Cancer Vaccines Market Size by Application (2014-2019) (Million US$)
Table United States Dendritic Cell Cancer Vaccines Market Share by Application (2014-2019)
Figure Europe Dendritic Cell Cancer Vaccines Market Size 2014-2019 (Million US$)
Table Europe Key Players Dendritic Cell Cancer Vaccines Revenue (2018-2019) (Million US$)
Table Europe Key Players Dendritic Cell Cancer Vaccines Market Share (2018-2019)
Table Europe Dendritic Cell Cancer Vaccines Market Size by Type (2014-2019) (Million US$)
Table Europe Dendritic Cell Cancer Vaccines Market Share by Type (2014-2019)
Table Europe Dendritic Cell Cancer Vaccines Market Size by Application (2014-2019) (Million US$)
Table Europe Dendritic Cell Cancer Vaccines Market Share by Application (2014-2019)
Figure China Dendritic Cell Cancer Vaccines Market Size 2014-2019 (Million US$)
Table China Key Players Dendritic Cell Cancer Vaccines Revenue (2018-2019) (Million US$)
Table China Key Players Dendritic Cell Cancer Vaccines Market Share (2018-2019)
Table China Dendritic Cell Cancer Vaccines Market Size by Type (2014-20189) (Million US$)
Table China Dendritic Cell Cancer Vaccines Market Share by Type (2014-2019)
Table China Dendritic Cell Cancer Vaccines Market Size by Application (2014-2019) (Million US$)
Table China Dendritic Cell Cancer Vaccines Market Share by Application (2014-2019)
Figure Japan Dendritic Cell Cancer Vaccines Market Size 2014-2019 (Million US$)
Table Japan Key Players Dendritic Cell Cancer Vaccines Revenue (2018-2019) (Million US$)
Table Japan Key Players Dendritic Cell Cancer Vaccines Market Share (2018-2019)
Table Japan Dendritic Cell Cancer Vaccines Market Size by Type (2014-2019) (Million US$)
Table Japan Dendritic Cell Cancer Vaccines Market Share by Type (2014-2019)
Table Japan Dendritic Cell Cancer Vaccines Market Size by Application (2014-2019) (Million US$)
Table Japan Dendritic Cell Cancer Vaccines Market Share by Application (2014-2019)
Figure Southeast Asia Dendritic Cell Cancer Vaccines Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Dendritic Cell Cancer Vaccines Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Dendritic Cell Cancer Vaccines Market Share (2018-2019)
Table Southeast Asia Dendritic Cell Cancer Vaccines Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Dendritic Cell Cancer Vaccines Market Share by Type (2014-2019)
Table Southeast Asia Dendritic Cell Cancer Vaccines Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Dendritic Cell Cancer Vaccines Market Share by Application (2014-2019)
Figure India Dendritic Cell Cancer Vaccines Market Size 2014-2019 (Million US$)
Table India Key Players Dendritic Cell Cancer Vaccines Revenue (2018-2019) (Million US$)
Table India Key Players Dendritic Cell Cancer Vaccines Market Share (2018-2019)
Table India Dendritic Cell Cancer Vaccines Market Size by Type (2014-2019) (Million US$)
Table India Dendritic Cell Cancer Vaccines Market Share by Type (2014-2019)
Table India Dendritic Cell Cancer Vaccines Market Size by Application (2014-2019) (Million US$)
Table India Dendritic Cell Cancer Vaccines Market Share by Application (2014-2019)
Figure Central & South America Dendritic Cell Cancer Vaccines Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Dendritic Cell Cancer Vaccines Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Dendritic Cell Cancer Vaccines Market Share (2018-2019)
Table Central & South America Dendritic Cell Cancer Vaccines Market Size by Type (2014-2019) (Million US$)
Table Central & South America Dendritic Cell Cancer Vaccines Market Share by Type (2014-2019)
Table Central & South America Dendritic Cell Cancer Vaccines Market Size by Application (2014-2019) (Million US$)
Table Central & South America Dendritic Cell Cancer Vaccines Market Share by Application (2014-2019)
Table 3M Company Company Details
Table 3M Company Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019) (Million US$)
Figure 3M Company Revenue Growth Rate in Dendritic Cell Cancer Vaccines Business (2014-2019)
Table 3M Company Recent Development
Table Activarti Company Details
Table Activarti Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)(Million US$)
Figure Activarti Revenue Growth Rate in Dendritic Cell Cancer Vaccines Business (2014-2019)
Table Activarti Recent Development
Table Argos Therapeutics Company Details
Table Argos Therapeutics Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)(Million US$)
Figure Argos Therapeutics Revenue Growth Rate in Dendritic Cell Cancer Vaccines Business (2014-2019)
Table Argos Therapeutics Recent Development
Table Batavia Bioservices Company Details
Table Batavia Bioservices Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)(Million US$)
Figure Batavia Bioservices Revenue Growth Rate in Dendritic Cell Cancer Vaccines Business (2014-2019)
Table Batavia Bioservices Recent Development
Table Bellicum Pharmaceuticals Company Details
Table Bellicum Pharmaceuticals Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)(Million US$)
Figure Bellicum Pharmaceuticals Revenue Growth Rate in Dendritic Cell Cancer Vaccines Business (2014-2019)
Table Bellicum Pharmaceuticals Recent Development
Table Creagene Company Details
Table Creagene Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)(Million US$)
Figure Creagene Revenue Growth Rate in Dendritic Cell Cancer Vaccines Business (2014-2019)
Table Creagene Recent Development
Table DanDrit Biotech Company Details
Table DanDrit Biotech Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)(Million US$)
Figure DanDrit Biotech Revenue Growth Rate in Dendritic Cell Cancer Vaccines Business (2014-2019)
Table DanDrit Biotech Recent Development
Table DCPrime Company Details
Table DCPrime Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)(Million US$)
Figure DCPrime Revenue Growth Rate in Dendritic Cell Cancer Vaccines Business (2014-2019)
Table DCPrime Recent Development
Table Sanpower Corporation Company Details
Table Sanpower Corporation Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)(Million US$)
Figure Sanpower Corporation Revenue Growth Rate in Dendritic Cell Cancer Vaccines Business (2014-2019)
Table Sanpower Corporation Recent Development
Table Elios Therapeutics Company Details
Table Elios Therapeutics Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)(Million US$)
Figure Elios Therapeutics Revenue Growth Rate in Dendritic Cell Cancer Vaccines Business (2014-2019)
Table Elios Therapeutics Recent Development
Table ImmunoCellular Therapeutics Company Details
Table Immunicum Company Details
Table Kiromic Company Details
Table Medigene Company Details
Table Merck Company Details
Table Northwest Biotherapeutics Company Details
Table Glaxo Smith Kline Company Details
Table Tellaorporation Company Details
Table Vaxil BioTherapeutics Company Details
Table Global Dendritic Cell Cancer Vaccines Market Size by Regions (Million US$) 2019-2025
Figure Global Dendritic Cell Cancer Vaccines Market Size Share by Regions (2019-2025)
Figure Global Dendritic Cell Cancer Vaccines Market Size Share by Regions in 2025
Figure United States Dendritic Cell Cancer Vaccines Market Size Forecast (2019-2025)(Million USD)
Figure Europe Dendritic Cell Cancer Vaccines Market Size Forecast (2019-2025)(Million USD)
Figure China Dendritic Cell Cancer Vaccines Market Size Forecast (2019-2025)(Million USD)
Figure Japan Dendritic Cell Cancer Vaccines Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Dendritic Cell Cancer Vaccines Market Size Forecast (2019-2025)(Million USD)
Figure India Dendritic Cell Cancer Vaccines Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Dendritic Cell Cancer Vaccines Market Size Forecast (2019-2025)(Million USD)
Table Global Dendritic Cell Cancer Vaccines Market Size by Product (2019-2025) (Million US$)
Figure Global Dendritic Cell Cancer Vaccines Market Size by Product (2019-2025)
Figure Global Dendritic Cell Cancer Vaccines Market Size by Product in 2025
Table Global Dendritic Cell Cancer Vaccines Market Size by Application (2019-2025) (Million US$)
Figure Global Dendritic Cell Cancer Vaccines Market Size by Application (2019-2025)
Figure Global Dendritic Cell Cancer Vaccines Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介

世界のワクチンと予防接種市場：市場規模・現状・予測

Global Vaccines & Vaccination Market Size, Status and Forecast 2019-2025
QYR9N8164 2019年6月14日 99Pages
当資料は、ワクチンと予防接種のグローバル市場について調査・分析したレポートで、種類別（サブユニットワクチン、弱毒化生ワクチン、コンジュゲートワクチン、不活化ワクチン、組換えベクターワクチン、その他）、用途別（小児科疾患市場、世界の成人病）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、イ...

世界の移行上皮がん治療薬市場：市場規模・現状・予測

Global Transitional Cell Cancer Therapeutics Market Size, Status and Forecast 2019-2025
QYR9N8141 2019年6月14日 95Pages
当資料は、移行上皮がん治療薬のグローバル市場について調査・分析したレポートで、種類別（膀胱腫瘍の経尿道的切除、膀胱切除術、尿路変更）、用途別（病院、がん研究所、多専門クリニック、外来手術センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企...

世界の最新がんワクチン市場2019

Global Emerging Cancer Vaccines Sales Market Report 2019
QYR9N0778 2019年6月10日 100Pages
本調査レポートでは、最新がんワクチンの世界市場について調査・分析し、最新がんワクチンのメーカー別販売量、市場シェア分析、種類別販売分析（非遺伝性ワクチン、遺伝子ワクチン）、用途別販売分析（がん研究センター、がん病院、診療所、その他）、地域別販売分析（米国、ヨーロッパ、中国、日本、東南アジア、インド）...

世界の予防的B型肝炎ウイルスワクチン市場：市場規模・現状・予測

Global Prophylactic Hepatitis B Virus Vaccines Market Size, Status and Forecast 2019-2025
QYR9N7889 2019年6月14日 93Pages
当資料は、予防的B型肝炎ウイルスワクチンのグローバル市場について調査・分析したレポートで、種類別（B型肝炎、肝硬変、肝細胞がん、肝不全）、用途別（病院、診療所）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

世界のRNAベースの治療薬とワクチン市場：市場規模・現状・予測

Global RNA-Based Therapeutics and Vaccines Market Size, Status and Forecast 2019-2025
QYR9N7978 2019年6月14日 97Pages
当資料は、RNAベースの治療薬とワクチンのグローバル市場について調査・分析したレポートで、種類別（RNAベースの治療薬、RNAベースのワクチン）、用途別（腫瘍学、免疫学、眼科、心血管疾患、感染症、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測...

世界の予防用ヒトワクチン市場：市場規模・現状・予測

Global Prophylactic Human Vaccines Market Size, Status and Forecast 2019-2025
QYR9N7890 2019年6月14日 107Pages
当資料は、予防用ヒトワクチンのグローバル市場について調査・分析したレポートで、種類別（タイプI、タイプII）、用途別（小児予防ワクチン、成人予防ワクチン）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
...

世界の腎臓がん市場：市場規模・現状・予測

Global Kidney Cancer Market Size, Status and Forecast 2019-2025
QYR9N7423 2019年6月14日 94Pages
当資料は、腎臓がんのグローバル市場について調査・分析したレポートで、種類別（腎細胞がん（RCC）、移行上皮がん（TCC））、用途別（手術、免疫療法、化学療法、放射線療法）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています...

世界の肺がんの診断と治療市場：市場規模・現状・予測

Global Lung Cancer Diagnosis and Therapeutics Market Size, Status and Forecast 2019-2025
QYR9N7483 2019年6月14日 103Pages
当資料は、肺がんの診断と治療のグローバル市場について調査・分析したレポートで、種類別（非小細胞肺がん、小細胞肺がん）、用途別（病院、がん研究センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

世界の皮膚がんの診断と治療市場：市場規模・現状・予測

Global Skin Cancer Diagnosis and Therapeutics Market Size, Status and Forecast 2019-2025
QYR9N8050 2019年6月14日 104Pages
当資料は、皮膚がんの診断と治療のグローバル市場について調査・分析したレポートで、種類別（日光角化症（AK）、ベース細胞がん（BCC）、扁平上皮がん（SCC）、メラノーマ）、用途別（病院、がん研究センター、診療所）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、...

世界の皮膚ガン市場：市場規模・現状・予測

Global Skin Cancer Market Size, Status and Forecast 2019-2025
QYR9N8049 2019年6月14日 103Pages
当資料は、皮膚ガンのグローバル市場について調査・分析したレポートで、種類別（基底細胞がん、扁平上皮がん）、用途別（病院、診療所、診断センター、がん研究所）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
...

世界の移行上皮がん治療薬市場：市場規模・現状・予測 Transitional cell carcinoma (TCC) occur in the different parts of urinary tract, which include kidney, bladder, or urethra.Market revenue drivers for the transitional cell cancer therapeutics market include increase in environmental pollution levels coupled with high rates of cigarette smoking. In 2…
世界のワクチンと予防接種市場：市場規模・現状・予測 Vaccination is the administration of antigenic material (avaccine) to stimulate an individual's immune system to develop adaptive immunity to a pathogen. Vaccines can prevent or ameliorate infectious disease.The increasing popularity of pediatric, travel, addiction, and pediatric combination vaccine…
世界の最新がんワクチン市場2019 Genetic vaccines are emerging as promising methodologies to elicit immune responses against a wide variety of antigens. The global Emerging Cancer Vaccines market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This re…
世界の腎臓がん市場：市場規模・現状・予測 Kidney cancer is a type of cancer that starts in the cells in the kidney.The growth of the market is attributed to increasing incidence of kidney cancers and increasing ill lifestyle changes which gets worsen with addiction of tobacco and alcohol. Furthermore, overexposure to radiation during treatm…
世界の肺がんの診断と治療市場：市場規模・現状・予測 Lung cancer is a malignant lung tumor characterized by uncontrolled cell growth in tissues of the lung.Robust healthcare expenditure within the developed countries, increasing pollution, government initiatives for lung cancer, and rising cases of smoking are some of the major factors that fuel the g…